Alembic Pharmaceuticals receives USFDA approval for generic Carbidopa, Levodopa, and Entacapone tablets to treat Parkinson's ...
More than 1 million Americans live with the neurodegenerative brain disorder – and that number is expected to climb ...
A new study suggests Parkinson’s may stem from disruptions in a little-known brain network, reshaping how doctors think about ...
Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year.